358 related articles for article (PubMed ID: 2875280)
1. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.
Meade TW; Mellows S; Brozovic M; Miller GJ; Chakrabarti RR; North WR; Haines AP; Stirling Y; Imeson JD; Thompson SG
Lancet; 1986 Sep; 2(8506):533-7. PubMed ID: 2875280
[TBL] [Abstract][Full Text] [Related]
2. Menopausal status and haemostatic variables.
Meade TW; Haines AP; Imeson JD; Stirling Y; Thompson SG
Lancet; 1983 Jan; 1(8314-5):22-4. PubMed ID: 6129369
[TBL] [Abstract][Full Text] [Related]
3. Haemostatic function and cardiovascular death: early results of a prospective study.
Meade TW; North WR; Chakrabarti R; Stirling Y; Haines AP; Thompson SG; Brozovié M
Lancet; 1980 May; 1(8177):1050-4. PubMed ID: 6103391
[TBL] [Abstract][Full Text] [Related]
4. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease.
Meade TW; Imeson J; Stirling Y
Lancet; 1987 Oct; 2(8566):986-8. PubMed ID: 2889958
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of hemostatic variables on fatal coronary heart disease: 30-year results from the first prospective Northwick Park Heart Study (NPHS-I).
De Stavola BL; Meade TW
J Thromb Haemost; 2007 Mar; 5(3):461-71. PubMed ID: 17137470
[TBL] [Abstract][Full Text] [Related]
6. Coagulation factor VII and the risk of coronary heart disease in healthy men.
Junker R; Heinrich J; Schulte H; van de Loo J; Assmann G
Arterioscler Thromb Vasc Biol; 1997 Aug; 17(8):1539-44. PubMed ID: 9301633
[TBL] [Abstract][Full Text] [Related]
7. An international and interregional comparison of haemostatic variables in the study of ischaemic heart disease. Report of a working group.
Meade TW; Stirling Y; Thompson SG; Vickers MV; Woolf L; Ajdukiewicz AB; Stewart G; Davidson JF; Walker ID; Douglas AS
Int J Epidemiol; 1986 Sep; 15(3):331-6. PubMed ID: 3095254
[TBL] [Abstract][Full Text] [Related]
8. Hypercoagulability and ischaemic heart disease.
Meade TW
Blood Rev; 1987 Mar; 1(1):2-8. PubMed ID: 3332083
[TBL] [Abstract][Full Text] [Related]
9. Haemostatic factors associated with ischaemic heart disease in men aged 45 to 64 years. The Speedwell study.
Baker IA; Eastham R; Elwood PC; Etherington M; O'Brien JR; Sweetnam PM
Br Heart J; 1982 May; 47(5):490-4. PubMed ID: 7073911
[TBL] [Abstract][Full Text] [Related]
10. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study.
Meade TW; Ruddock V; Stirling Y; Chakrabarti R; Miller GJ
Lancet; 1993 Oct; 342(8879):1076-9. PubMed ID: 8105310
[TBL] [Abstract][Full Text] [Related]
11. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
Scarabin PY; Aillaud MF; Amouyel P; Evans A; Luc G; Ferrières J; Arveiler D; Juhan-Vague I
Thromb Haemost; 1998 Nov; 80(5):749-56. PubMed ID: 9843166
[TBL] [Abstract][Full Text] [Related]
12. Haemostatic/inflammatory markers predict 10-year risk of IHD at least as well as lipids: the Caerphilly collaborative studies.
Yarnell JW; Patterson CC; Sweetnam PM; Lowe GD
Eur Heart J; 2004 Jun; 25(12):1049-56. PubMed ID: 15191776
[TBL] [Abstract][Full Text] [Related]
13. Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease.
Miller GJ; Bauer KA; Barzegar S; Cooper JA; Rosenberg RD
Thromb Haemost; 1996 May; 75(5):767-71. PubMed ID: 8725721
[TBL] [Abstract][Full Text] [Related]
14. Haemostatic factors and prevalent coronary heart disease; the FINRISK Haemostasis Study.
Salomaa V; Rasi V; Pekkanen J; Vahtera E; Jauhiainen M; Vartiainen E; Myllylä G; Ehnholm C
Eur Heart J; 1994 Oct; 15(10):1293-9. PubMed ID: 7821305
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies.
Yarnell JW; Baker IA; Sweetnam PM; Bainton D; O'Brien JR; Whitehead PJ; Elwood PC
Circulation; 1991 Mar; 83(3):836-44. PubMed ID: 1999035
[TBL] [Abstract][Full Text] [Related]
16. Haemostatic factors and ischaemic heart disease. The Caerphilly study.
Yarnell JW; Sweetnam PM; Elwood PC; Eastham R; Gilmour RA; O'Brien JR; Etherington MD
Br Heart J; 1985 May; 53(5):483-7. PubMed ID: 3994861
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen, factor VII clotting activity and coronary artery disease severity.
Broadhurst P; Kelleher C; Hughes L; Imeson JD; Raftery EB
Atherosclerosis; 1990 Dec; 85(2-3):169-73. PubMed ID: 2102080
[TBL] [Abstract][Full Text] [Related]
18. Plasma fibrinogen level is not elevated in young adults from families with premature ischemic heart disease.
Hoffman CJ; Burns P; Lawson WE; Katz JP; Miller RH; Hultin MB
Arterioscler Thromb; 1993 Jun; 13(6):800-3. PubMed ID: 8499399
[TBL] [Abstract][Full Text] [Related]
19. Platelet counts and aggregation measures in the incidence of ischaemic heart disease (IHD).
Meade TW; Cooper JA; Miller GJ
Thromb Haemost; 1997 Aug; 78(2):926-9. PubMed ID: 9268196
[TBL] [Abstract][Full Text] [Related]
20. Hemostasis and cardiovascular risk. The British and European experience.
Miller GJ
Arch Pathol Lab Med; 1992 Dec; 116(12):1318-21. PubMed ID: 1456878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
